Search Results

The Incite Interbody Fusion Device is intended for anterior intervertebral body fusion of the lumbar spine at one or two contiguous levels from L2-S1. The device is indicated for patients with lumbar degenerative disc disease (DDD) with up to Grade I spondylolisthesis at the involved level(s). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. Patients treated should be skeletally mature and have received a minimum of six months of non-operative treatment. The Incite Interbody Fusion Device is designed for use with additional supplemental fixation and with autograft to facilitate fusion.

The Incite Interbody Fusion Device (IBFD) is an ALIF implant that incorporates the benefit of a radiolucent interbody spacer equipped with internal fixation anteriorly through the use of an integrated anchoring mechanism. The implant is made from materials with a long history of use in this type of application which include PEEK, titanium alloy, and tantalum. The implant has two chambers to accommodate autograft.

I am sorry, but the provided text from the 510(k) summary (pages 0-3) for the "Incite Interbody Fusion Device" does not contain information regarding acceptance criteria, device performance, or any clinical study details such as sample sizes, data provenance, ground truth establishment, or expert involvement.

The document is a 510(k) summary, which typically focuses on demonstrating substantial equivalence to predicate devices based on design, materials, intended use, and mechanical performance. It details the device description, intended use, and lists predicate devices. It also includes the FDA's clearance letter.

Therefore, I cannot fulfill your request for the specific information about acceptance criteria and the study that proves the device meets those criteria based on the provided text.

Ask a specific question about this device